Natco Pharma Ltd logo

Natco Pharma Ltd

NSE : NATCOPHARM
BSE: 524816
SECTOR : PHARMACEUTICALS
No data to show from BSE
52w high/low icon
52w high/low
₹1189 / ₹771.5
P/E ratio icon
P/E ratio
83.17
Dividend icon
Dividend
0.71
ROE icon
ROE
3.32
ROCE icon
ROCE
3.68
Face value icon
Face value
2
Book value icon
Book value
₹229.62Cr
Market capital icon
Market capital
₹11,569.56Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.
Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:
Assets = Liabilities + Shareholder's Equity
This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM
83.17
P/B
2.76
ROE
3.32
ROCE
3.68
Dividend yield
0.71%
EPS TTM
7.62
EBTIDA Growth
-26.09
D/E
0.1
Sector PE
34.81
BV
₹229.62Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.
Natco Pharma Ltd logo

About Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States, India, Europe and the rest of the world (RoW). Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. Natco Pharma was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited.

Key info

Address
Natco House, Road No 2 Banjara Hills, Hyderabad, Telangana, 500033
Fax Nos.
91-040-23548243
Telephone Nos.
91-040-23547532
Email
investors@natcopharma.co.in
fbtwitterlinkedingithubinstagramyoutube